Lipidation Approaches Potentiate Adjuvant-Pulsed Immune Surveillance: A Design Rationale for Cancer Nanovaccine

Area of Science:

• Nanotechnology
• Immunology
• Vaccine Development

Background:

• Adjuvant-pulsed peptide vaccines show promise but face challenges like poor tolerability and antigen instability.
• Existing methods struggle with efficient delivery, cellular uptake, and preventing systemic adverse effects.

Purpose of the Study:

• To develop a robust lipidation approach for co-delivering immunomodulators and peptides via polymer-lipid hybrid nanoparticles (PLNs).
• To enhance vaccine efficacy by improving hydrophobicity, cellular association, and sustained release of vaccine components.

Main Methods:

• Lipidation of low-molecular-weight immunomodulators (TLR7/8 agonists) and peptides (SIINFEKL) using C16 chains.
• Formulation of lipidated components into polymer-lipid hybrid nanoparticles (PLNs) for co-delivery.
• Evaluation of *in vivo* prophylactic effects, including immune cell activation and tumor suppression.

Main Results:

• Lipidation increased hydrophobicity, improving encapsulation and facilitating cellular interactions.
• PLNs demonstrated sustained antigen/adjuvant levels with reduced systemic exposure.
• The lipidated nanovaccine effectively enhanced antigen-specific CD8+ T cell expansion and activation.
• Significant tumor suppression and improved overall survival were observed in a prophylactic setting.

Conclusions:

• Lipidation is a viable strategy to enhance nanovaccine efficacy for cancer therapy.
• The developed nanovaccine platform shows potential for robust anti-tumor immune responses.
• This methodology offers a promising approach for next-generation nanovaccines.